FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070095 [Registered on: 05/07/2024] Trial Registered Prospectively
Last Modified On: 25/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   IMPACT OF CHRONIC KIDNEY DISEASE ON THYROID HORMONE LEVELS 
Scientific Title of Study   Study of thyroid profile in patients with chronic kidney disease in tertiary care center 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sushrut Gupta 
Designation  Senior Resident  
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Datta Meghe Institute of Higher Education and Research

Wardha
MAHARASHTRA
442001
India 
Phone  9557612010  
Fax    
Email  drsushrutguptamd1995@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amit Pasari 
Designation  Professor  
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Datta Meghe Institute of Higher Education and Research

Wardha
MAHARASHTRA
442001
India 
Phone  9422164630  
Fax    
Email  dramit2811@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Amit Pasari 
Designation  Professor  
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Datta Meghe Institute of Higher Education and Research

Wardha
MAHARASHTRA
442001
India 
Phone  9422164630  
Fax    
Email  dramit2811@gmail.com  
 
Source of Monetary or Material Support  
JAWAHARLAL NEHRU MEDICAL COLLEGE,Datta Meghe Institute of Higher Education and Research,SAWANGI(MEGHE),WARDHA,MAHARASHTRA,INDIA 
 
Primary Sponsor  
Name  None 
Address  Nil 
Type of Sponsor  Other [Nil] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sushrut Gupta  Datta Meghe Institute of Higher Education and Research  DEPARTMENT OF NEPHROLOGY
Wardha
MAHARASHTRA 
9557612010

drsushrutguptamd1995@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Datta Meghe Institute of Medical Sciences Sawangi (Meghe) Wardha  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I00-I99||Diseases of the circulatory system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  All patients of Chronic Kidney Disease above the age of 18 years. Patients voluntarily willing to give informed consent will be taken for this study.
 
 
ExclusionCriteria 
Details  Family history of thyroid disorder. Known case of thyroid disorders whether having medication or not. History of any surgery or any radiological intervention to thyroid gland. Patients on drugs altering thyroid profile such as amiodarone, phenytoin, oestrogen pills and iodine containing drugs. Pregnant females.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The primary outcome of the study could be defined as the prevalence of thyroid function abnormalities (such as subclinical hypothyroidism, overt hypothyroidism, hyperthyroidism, and low T3 syndrome) in patients with chronic kidney disease (CKD), categorized according to different stages.  BASELINE AND 12 WEEKS 
 
Secondary Outcome  
Outcome  TimePoints 
This study aims to examine thyroid function in chronic kidney disease (CKD) patients across different stages and assess the prevalence of thyroid abnormalities. Secondary outcomes include investigating correlations between thyroid function and CKD stages, as well as changes in quality of life, estimated glomerular filtration rate (eGFR), and Body Mass Index (BMI) after 3 months of treatment in non-dialysis CKD patients.  1 Month 
 
Target Sample Size   Total Sample Size="105"
Sample Size from India="105" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study proposes to investigate the thyroid profile in patients with chronic kidney disease (CKD) in a tertiary care center. The rationale underscores the importance of understanding the relationship between thyroid hormones and CKD due to overlapping symptoms and potential treatment implications. The objectives include evaluating thyroid function, correlating abnormalities with CKD stages, assessing quality of life, and monitoring changes after treatment. Ethical approval and informed consent will be obtained, with data collected through patient history, examination, and laboratory tests. Statistical analysis will be conducted using SPSS software. The study aims to contribute valuable insights into thyroid function in CKD patients, potentially informing clinical management strategies. 
Close